Home
Applications
Indications
Business
EpiSwitch
®
Products
EpiSwitch
®
Explorer Kit
EpiSwitch
®
Service
Investors
Investors Overview
Results and Presentations
Share Price Information
Regulatory News
Board & Governance
Key Corporate Documents
AIM Rule 26
Email Alerts
Investor Contacts
News
About Us
History
Board of Directors
Management Team
Scientific Advisory Panel
Values
Careers
OBD organised a press conference to announce its Diabetes epigenetics study.
June 2, 2016
|
In
Events
|
By
Aroul Ramadass
Press release for Malaysian Diabetes biomarker discovery programme
Prev
Next
Privacy Preference Center
Privacy Preferences
